ALGN
Price
$128.66
Change
-$0.34 (-0.26%)
Updated
Sep 24, 11:44 AM (EDT)
Capitalization
9.35B
35 days until earnings call
BAX
Price
$22.84
Change
-$0.03 (-0.13%)
Updated
Sep 24, 11:47 AM (EDT)
Capitalization
11.74B
36 days until earnings call
Interact to see
Advertisement

ALGN vs BAX

Header iconALGN vs BAX Comparison
Open Charts ALGN vs BAXBanner chart's image
Align Technology
Price$128.66
Change-$0.34 (-0.26%)
Volume$200
Capitalization9.35B
Baxter International
Price$22.84
Change-$0.03 (-0.13%)
Volume$2.14K
Capitalization11.74B
ALGN vs BAX Comparison Chart in %
Loading...
ALGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALGN vs. BAX commentary
Sep 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALGN is a StrongBuy and BAX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 24, 2025
Stock price -- (ALGN: $129.00 vs. BAX: $22.86)
Brand notoriety: ALGN: Notable vs. BAX: Not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ALGN: 55% vs. BAX: 59%
Market capitalization -- ALGN: $9.35B vs. BAX: $11.74B
ALGN [@Pharmaceuticals: Other] is valued at $9.35B. BAX’s [@Pharmaceuticals: Other] market capitalization is $11.74B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $160.51B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.14B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALGN’s FA Score shows that 0 FA rating(s) are green whileBAX’s FA Score has 2 green FA rating(s).

  • ALGN’s FA Score: 0 green, 5 red.
  • BAX’s FA Score: 2 green, 3 red.
According to our system of comparison, BAX is a better buy in the long-term than ALGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALGN’s TA Score shows that 4 TA indicator(s) are bullish while BAX’s TA Score has 4 bullish TA indicator(s).

  • ALGN’s TA Score: 4 bullish, 3 bearish.
  • BAX’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, both ALGN and BAX are a good buy in the short-term.

Price Growth

ALGN (@Pharmaceuticals: Other) experienced а -2.14% price change this week, while BAX (@Pharmaceuticals: Other) price change was -4.23% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.28%. For the same industry, the average monthly price growth was -1.82%, and the average quarterly price growth was +9.28%.

Reported Earning Dates

ALGN is expected to report earnings on Oct 29, 2025.

BAX is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-0.28% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BAX($11.7B) has a higher market cap than ALGN($9.35B). BAX has higher P/E ratio than ALGN: BAX (87.85) vs ALGN (21.79). BAX YTD gains are higher at: -20.229 vs. ALGN (-38.132). BAX has higher annual earnings (EBITDA): 1.04B vs. ALGN (793M). BAX has more cash in the bank: 1.69B vs. ALGN (901M). ALGN has less debt than BAX: ALGN (123M) vs BAX (9.73B). BAX has higher revenues than ALGN: BAX (10.9B) vs ALGN (3.97B).
ALGNBAXALGN / BAX
Capitalization9.35B11.7B80%
EBITDA793M1.04B77%
Gain YTD-38.132-20.229189%
P/E Ratio21.7987.8525%
Revenue3.97B10.9B36%
Total Cash901M1.69B53%
Total Debt123M9.73B1%
FUNDAMENTALS RATINGS
ALGN vs BAX: Fundamental Ratings
ALGN
BAX
OUTLOOK RATING
1..100
5463
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
19
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
6692
PRICE GROWTH RATING
1..100
6565
P/E GROWTH RATING
1..100
9429
SEASONALITY SCORE
1..100
n/a65

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BAX's Valuation (19) in the Medical Specialties industry is somewhat better than the same rating for ALGN (73). This means that BAX’s stock grew somewhat faster than ALGN’s over the last 12 months.

BAX's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as ALGN (100). This means that BAX’s stock grew similarly to ALGN’s over the last 12 months.

ALGN's SMR Rating (66) in the Medical Specialties industry is in the same range as BAX (92). This means that ALGN’s stock grew similarly to BAX’s over the last 12 months.

ALGN's Price Growth Rating (65) in the Medical Specialties industry is in the same range as BAX (65). This means that ALGN’s stock grew similarly to BAX’s over the last 12 months.

BAX's P/E Growth Rating (29) in the Medical Specialties industry is somewhat better than the same rating for ALGN (94). This means that BAX’s stock grew somewhat faster than ALGN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALGNBAX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
62%
Momentum
ODDS (%)
Bearish Trend 2 days ago
66%
Bearish Trend 2 days ago
64%
MACD
ODDS (%)
Bullish Trend 6 days ago
73%
Bearish Trend 2 days ago
67%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
60%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
62%
Advances
ODDS (%)
Bullish Trend 20 days ago
75%
Bullish Trend 20 days ago
52%
Declines
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 3 days ago
60%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
67%
Aroon
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
57%
View a ticker or compare two or three
Interact to see
Advertisement
ALGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FEUZ58.42N/A
-0.01%
First Trust Eurozone AlphaDEX® ETF
RFEU70.65-0.08
-0.12%
First Trust RiverFront Dynamic Eurp ETF
RSSB28.23-0.03
-0.12%
Return Stacked Global Stocks & Bonds ETF
CET51.35-0.35
-0.68%
Central Securities Corp
BCOR34.50-0.46
-1.32%
Grayscale Bitcoin Adopters ETF

ALGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALGN has been loosely correlated with BAX. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if ALGN jumps, then BAX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALGN
1D Price
Change %
ALGN100%
-1.66%
BAX - ALGN
62%
Loosely correlated
+0.22%
JNDOF - ALGN
60%
Loosely correlated
N/A
LUNG - ALGN
54%
Loosely correlated
-1.09%
ITGR - ALGN
44%
Loosely correlated
-0.48%
NVST - ALGN
43%
Loosely correlated
-0.24%
More

BAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BAX has been loosely correlated with ALGN. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if BAX jumps, then ALGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BAX
1D Price
Change %
BAX100%
+0.22%
ALGN - BAX
60%
Loosely correlated
-1.66%
LUNG - BAX
53%
Loosely correlated
-1.09%
STE - BAX
51%
Loosely correlated
-0.19%
SYK - BAX
51%
Loosely correlated
-1.24%
SOLV - BAX
50%
Loosely correlated
-0.50%
More